Oramed Pharmaceuticals
ORMP
#8931
Rank
S$0.12 B
Marketcap
$3.21
Share price
-4.82%
Change (1 day)
1.84%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): S$33.12 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of S$9.65 Million, an increase over its 2022 earnings that were of -S$49.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$33.12 M243.13%
2023 S$9.65 M-119.45%
2022 -S$49.64 Million39.17%
2021 -S$35.67 Million73.93%
2020 -S$20.51 Million18.53%
2019 -S$17.3 Million-16.62%
2018 -S$20.75 Million38.32%
2017 -S$15 Million12.51%
2016 -S$13.34 Million25.01%
2015 -S$10.67 Million18.18%
2014 -S$9.03 Million39.72%
2013 -S$6.46 Million46.4%
2012 -S$4.42 Million128.32%
2011 -S$1.94 Million-51.47%
2010 -S$3.99 Million35.21%
2009 -S$2.95 Million
2007 -S$4.64 Million607.04%
2006 -S$0.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.68 Billion-2,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.17 B 72,308.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
S$10.03 B 29,960.63%๐Ÿ‡ซ๐Ÿ‡ท France
S$20.49 M-38.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-S$0.3 Billion-978.11%๐Ÿ‡บ๐Ÿ‡ธ USA